2022
DOI: 10.3390/ijms23147554
|View full text |Cite
|
Sign up to set email alerts
|

Extracellular Vesicles—Oral Therapeutics of the Future

Abstract: Considered an artifact just after discovery, the possibility of oral delivery of extracellular vesicles (EVs) and their functional cargos has recently gained much research attention. EVs from various sources, including edible plants, milk, bacteria and mammalian cells, have emerged as a platform for miRNA and drug delivery that seem to induce the expected immune effects locally and in distant tissues after oral administration. Such a possibility greatly expands the clinical applicability of EVs. The present re… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
14
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(15 citation statements)
references
References 127 publications
1
14
0
Order By: Relevance
“…As it can be relatively easily observed, a large amount of research on EVs produced by probiotics focuses on the evaluation of the biological effect of these structures only on the gastrointestinal system. For obvious reasons, including the ingestible administration of probiotic EVs, the action of these structures on the digestive system is highly intuitive and justified [ 154 , 155 ]. However, it should still be remembered that EVs, due to their nanometric dimensions, can reach various tissues of the host, and, therefore, their effect on different types of human cells should be discovered [ 13 , 156 ].…”
Section: Discussionmentioning
confidence: 99%
“…As it can be relatively easily observed, a large amount of research on EVs produced by probiotics focuses on the evaluation of the biological effect of these structures only on the gastrointestinal system. For obvious reasons, including the ingestible administration of probiotic EVs, the action of these structures on the digestive system is highly intuitive and justified [ 154 , 155 ]. However, it should still be remembered that EVs, due to their nanometric dimensions, can reach various tissues of the host, and, therefore, their effect on different types of human cells should be discovered [ 13 , 156 ].…”
Section: Discussionmentioning
confidence: 99%
“…Murine studies identifying the biodistribution pattern of orally administered sEVs are few and focus mainly on cow’s milk-derived sEVs, although we have found some studies using plant-derived exosomes-like particles. These studies show that sEVs/exosomes-like particles manage to withstand the hostile environment of the gastrointestinal tract, associated with their transit through acidic conditions in the stomach and degradative conditions in the gut, in various murine models [ 24 , 25 , 26 ]. Cow’s milk-derived sEVs cross the upper gastrointestinal tract and reach the intestine in relatively short times (1–6 h) [ 27 , 28 ].…”
Section: Biodistribution Stability and Safety Of Oral Delivery Of Nat...mentioning
confidence: 99%
“…Table 3 presents a summary of these articles, where they were classified according to the source of sEVs, the attribute or modification studied, the use of sEVs as a drug nanocarrier, and the observed biological effect and the type of models utilized. As a note to mention, most articles on the oral administration of sEVs are based on the use of vesicles derived from edible compounds (fruits, vegetables, spices, milk, or its derivatives), as extensively reviewed by Ciéslik et al [ 24 ].…”
Section: Sevs Attributes For An Efficient Oral Administrationmentioning
confidence: 99%
See 1 more Smart Citation
“…Bacterial-derived extracellular vesicles (EVs) are often candidates for mucosal vaccines to induce immune protection against specific pathogens [55]. In addition, bacterial-derived EVs in urine can be used as novel biomarkers for the noninvasive diagnosis of gastric cancer [56].…”
Section: The Sources Of Exosomesmentioning
confidence: 99%